The Molecular and Phenotypic Basis of the Glioma Invasive Perivascular Niche

Gliomas are devastating brain cancers that have poor prognostic outcomes for their patients. Short overall patient survival is due to a lack of durable, efficacious treatment options. Such therapeutic difficulties exist, in part, due to several glioma survival adaptations and mechanisms, which allow...

Full description

Bibliographic Details
Main Authors: Mohammed Diksin, Stuart J. Smith, Ruman Rahman
Format: Article
Language:English
Published: MDPI AG 2017-11-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/18/11/2342
id doaj-7bd3ed2c0407442fa30d05b852ce97c4
record_format Article
spelling doaj-7bd3ed2c0407442fa30d05b852ce97c42020-11-25T02:17:56ZengMDPI AGInternational Journal of Molecular Sciences1422-00672017-11-011811234210.3390/ijms18112342ijms18112342The Molecular and Phenotypic Basis of the Glioma Invasive Perivascular NicheMohammed Diksin0Stuart J. Smith1Ruman Rahman2Children’s Brain Tumour Research Centre, School of Medicine, University of Nottingham, Nottingham NG7 2UH, UKChildren’s Brain Tumour Research Centre, School of Medicine, University of Nottingham, Nottingham NG7 2UH, UKChildren’s Brain Tumour Research Centre, School of Medicine, University of Nottingham, Nottingham NG7 2UH, UKGliomas are devastating brain cancers that have poor prognostic outcomes for their patients. Short overall patient survival is due to a lack of durable, efficacious treatment options. Such therapeutic difficulties exist, in part, due to several glioma survival adaptations and mechanisms, which allow glioma cells to repurpose paracrine signalling pathways and ion channels within discreet microenvironments. These Darwinian adaptations facilitate invasion into brain parenchyma and perivascular space or promote evasion from anti-cancer defence mechanisms. Ultimately, this culminates in glioma repopulation and migration at distances beyond the original tumour site, which is a considerable obstacle for effective treatment. After an era of failed phase II trials targeting individual signalling pathways, coupled to our increasing knowledge of glioma sub-clonal divergence, combinatorial therapeutic approaches which target multiple molecular pathways and mechanisms will be necessary for better treatment outcomes in treating malignant gliomas. Furthermore, next-generation therapy which focuses on infiltrative tumour phenotypes and disruption of the vascular and perivascular microenvironments harbouring residual disease cells offers optimism for the localised control of malignant gliomas.https://www.mdpi.com/1422-0067/18/11/2342glioblastomatumour invasionperivascular nicheextracellular matrixchemokine
collection DOAJ
language English
format Article
sources DOAJ
author Mohammed Diksin
Stuart J. Smith
Ruman Rahman
spellingShingle Mohammed Diksin
Stuart J. Smith
Ruman Rahman
The Molecular and Phenotypic Basis of the Glioma Invasive Perivascular Niche
International Journal of Molecular Sciences
glioblastoma
tumour invasion
perivascular niche
extracellular matrix
chemokine
author_facet Mohammed Diksin
Stuart J. Smith
Ruman Rahman
author_sort Mohammed Diksin
title The Molecular and Phenotypic Basis of the Glioma Invasive Perivascular Niche
title_short The Molecular and Phenotypic Basis of the Glioma Invasive Perivascular Niche
title_full The Molecular and Phenotypic Basis of the Glioma Invasive Perivascular Niche
title_fullStr The Molecular and Phenotypic Basis of the Glioma Invasive Perivascular Niche
title_full_unstemmed The Molecular and Phenotypic Basis of the Glioma Invasive Perivascular Niche
title_sort molecular and phenotypic basis of the glioma invasive perivascular niche
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1422-0067
publishDate 2017-11-01
description Gliomas are devastating brain cancers that have poor prognostic outcomes for their patients. Short overall patient survival is due to a lack of durable, efficacious treatment options. Such therapeutic difficulties exist, in part, due to several glioma survival adaptations and mechanisms, which allow glioma cells to repurpose paracrine signalling pathways and ion channels within discreet microenvironments. These Darwinian adaptations facilitate invasion into brain parenchyma and perivascular space or promote evasion from anti-cancer defence mechanisms. Ultimately, this culminates in glioma repopulation and migration at distances beyond the original tumour site, which is a considerable obstacle for effective treatment. After an era of failed phase II trials targeting individual signalling pathways, coupled to our increasing knowledge of glioma sub-clonal divergence, combinatorial therapeutic approaches which target multiple molecular pathways and mechanisms will be necessary for better treatment outcomes in treating malignant gliomas. Furthermore, next-generation therapy which focuses on infiltrative tumour phenotypes and disruption of the vascular and perivascular microenvironments harbouring residual disease cells offers optimism for the localised control of malignant gliomas.
topic glioblastoma
tumour invasion
perivascular niche
extracellular matrix
chemokine
url https://www.mdpi.com/1422-0067/18/11/2342
work_keys_str_mv AT mohammeddiksin themolecularandphenotypicbasisofthegliomainvasiveperivascularniche
AT stuartjsmith themolecularandphenotypicbasisofthegliomainvasiveperivascularniche
AT rumanrahman themolecularandphenotypicbasisofthegliomainvasiveperivascularniche
AT mohammeddiksin molecularandphenotypicbasisofthegliomainvasiveperivascularniche
AT stuartjsmith molecularandphenotypicbasisofthegliomainvasiveperivascularniche
AT rumanrahman molecularandphenotypicbasisofthegliomainvasiveperivascularniche
_version_ 1724884175795781632